Results 201 to 210 of about 1,014,434 (264)

First-line ET plus palbociclib versus standard mono-chemotherapy in high-risk HR-positive/HER2-negative metastatic breast cancer and indication for chemotherapy: primary results from the randomized phase IV PADMA study. [PDF]

open access: yesESMO Open
Schmidt M   +18 more
europepmc   +1 more source

Institution within institution

open access: yesThe Annals of The Royal College of Surgeons of England
openaire   +1 more source

Correction. [PDF]

open access: yesDermatol Pract Concept
europepmc   +1 more source

Home - About - Disclaimer - Privacy